← Eichor
Condition: Food Safety Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Food Safety

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Food Effect of HSK55879 Tablets in Healt
Phase 1 · 1 location(s) · Haisco Pharmaceutical Group Co., Ltd. · NCT07521345Evaluation of a Health Promotion Intervention on Food Safety in Women During Pregnancy
Phase N/A · 1 location(s) · Centre Hospitalier de Cayenne · NCT06528535Study of TRX-100 Tablets Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy Volunteers
Phase 1 · 1 location(s) · Traws Pharma, Inc. · NCT07526506BnH-015B Clinical Trial in Moderate Alzheimer's Disease
Phase 1 · 1 location(s) · BnH Research · NCT06535308Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes
Phase 1 · 4 location(s) · OrsoBio, Inc · NCT05822544Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer S
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT06760754A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants
Phase 1 · 2 location(s) · AstraZeneca · NCT07290283Preliminary Human Trials of F230 Tablets
Phase 1 · 1 location(s) · Beijing Continent Pharmaceutical Co, Ltd. · NCT06899815SAR447971 First-in-human Study
Phase 1 · 1 location(s) · Sanofi · NCT07629336A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years
Phase 1 · 1 location(s) · Centessa Pharmaceuticals (UK) Limited · NCT07413666A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LG-0317 in Healthy Participants
Phase 1 · 1 location(s) · LinGang Laboratory · NCT07522970A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants a
Phase 1 · 5 location(s) · AstraZeneca · NCT07024823A Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have Narcolepsy
Phase 1 · 2 location(s) · H. Lundbeck A/S · NCT07613710A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to S
Phase 1 · 1 location(s) · Shanghai Qilu Pharmaceutical Research and Development Center · NCT06946641A Clinical Study of HRS-5765 in Healthy Participants
Phase 1 · 1 location(s) · Chengdu Suncadia Medicine Co., Ltd. · NCT07551167A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RS-C1001 Tablets in Chinese Healthy Subjec
Phase 1 · 1 location(s) · Peking University First Hospital · NCT06669429A Study to Evaluate the Effect of Food on the Bioavailability of AJ201, and Safety, Tolerability, and Pharmacokinetics o
Phase 1 · 1 location(s) · AnnJi Pharmaceutical Co., Ltd. · NCT07549919A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Hea
Phase 1 · 1 location(s) · Pfizer · NCT07660731Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD)
NA · 21 location(s) · Dr. Schär AG / SPA · NCT05489120A Phase I Clinical Trial to Evaluate the Single Dose Ascending and Food Effects of PG-033 in Healthy Adults
Phase 1 · 1 location(s) · Prime Gene Therapeutics Co., Ltd. · NCT07013097Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia
EARLY_Phase 1 · 1 location(s) · Neurosterix · NCT07344948First-into-human Study of NS-136 in Healthy Subjects
Phase 1 · 2 location(s) · NeuShen Therapeutics · NCT06345703A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of
Phase 1 · 1 location(s) · Enanta Pharmaceuticals, Inc · NCT07540910Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers
Phase 1 · 1 location(s) · Vigonvita Life Sciences · NCT06105151A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis
Phase 1 · 1 location(s) · Usynova Pharmaceuticals Ltd. · NCT07038720A Clinical Study of SPH7854 Granules in Healthy Subjects.
EARLY_Phase 1 · 1 location(s) · Shanghai Pharmaceuticals Holding Co., Ltd · NCT06483373First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07169318A Study of SIGX1094R in Patients With Advanced Solid Tumors
Phase 1 · 1 location(s) · Signet Therapeutics · NCT06739291Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118
Phase 1 · 1 location(s) · Jiangsu Hansoh Pharmaceutical Co., Ltd. · NCT07033234UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies
Phase 1/Phase 2 · 5 location(s) · Ukko Inc · NCT07349212
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.